Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.66% |
| 2 | Consumer Discretionary | 8.08% |
| 3 | Energy | 7.71% |
| 4 | Technology | 6.85% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
PUT
Children's Place
PLCE
$54.3M
| $1.01M | ﹤0.01% |
17,400
-17,700
| -50% | -$971K |
|
|
ARX
3002
DELISTED
Aeroflex Holding Corp (DE)
ARX
| $1.01M | ﹤0.01% |
143,034
+12,998
| +10% | +$98.4K |
|
|
ZVO
3003
DELISTED
Zovio Inc. Common Stock
ZVO
| $1M | ﹤0.01% |
55,685
-53,108
| -49% | -$864K |
|
3004
CALL
Steel Dynamics
STLD
$36.7B
| $1M | ﹤0.01% |
60,000
-14,300
| -19% | -$227K |
|
|
CYT
3005
PUT
DELISTED
CYTEC INDS INC
CYT
| $1M | ﹤0.01% |
24,600
-15,200
| -38% | -$590K |
|
3006
CALL
Ingredion
INGR
$6.63B
| $999K | ﹤0.01% |
15,100
+13,200
| +695% | +$862K |
|
|
AXE
3007
CALL
DELISTED
Anixter International Inc
AXE
| $999K | ﹤0.01% |
11,400
-4,300
| -27% | -$361K |
|
|
JAH
3008
CALL
DELISTED
JARDEN CORPORATION
JAH
| $999K | ﹤0.01% |
30,975
-28,350
| -48% | -$875K |
|
3009
CALL
FTI Consulting
FCN
$4.19B
| $998K | ﹤0.01% |
26,400
-11,100
| -30% | -$393K |
|
|
AXON
3010
PUT
Axon Enterprise
AXON
$49.8B
| $996K | ﹤0.01% |
66,800
+50,600
| +312% | +$543K |
|
3011
CALL
Lear
LEA
$8.32B
| $995K | ﹤0.01% |
13,900
-1,000
| -7% | -$68.8K |
|
3012
PUT
Federal Realty Investment Trust
FRT
$10.3B
| $994K | ﹤0.01% |
9,800
+1,800
| +23% | +$184K |
|
|
PLL
3013
CALL
DELISTED
PALL CORP
PLL
| $994K | ﹤0.01% |
12,900
+7,300
| +130% | +$523K |
|
|
BYI
3014
PUT
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $994K | ﹤0.01% |
+13,800
| New | +$972K |
|
3015
Pool Corp
POOL
$7.08B
| $993K | ﹤0.01% |
17,693
-28,692
| -62% | -$1.55M |
|
3016
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
| $992K | ﹤0.01% |
15,500
-6,300
| -29% | -$314K |
|
3017
Cadence Design Systems
CDNS
$89.5B
| $991K | ﹤0.01% |
73,373
+46,835
| +176% | +$672K |
|
|
XLS
3018
DELISTED
EXELIS INC COM STK
XLS
| $990K | ﹤0.01% |
67,501
-89,806
| -57% | -$1.26M |
|
3019
CALL
Quest Diagnostics
DGX
$25.9B
| $989K | ﹤0.01% |
16,000
-500
| -3% | -$29.9K |
|
3020
CALL
Alkermes
ALKS
$8.23B
| $988K | ﹤0.01% |
29,400
-3,800
| -11% | -$124K |
|
3021
CALL
IMAX
IMAX
$2.9B
| $986K | ﹤0.01% |
32,600
+15,800
| +94% | +$425K |
|
|
NFBK
3022
DELISTED
Northfield Bancorp
NFBK
| $984K | ﹤0.01% |
81,042
-75,617
| -48% | -$911K |
|
|
ERF
3023
PUT
DELISTED
Enerplus Corporation
ERF
| $984K | ﹤0.01% |
59,737
-32,841
| -35% | -$539K |
|
|
MDR
3024
DELISTED
McDermott International
MDR
| $984K | ﹤0.01% |
44,167
+37,624
| +575% | +$893K |
|
3025
LSB Industries
LXU
$737M
| $982K | ﹤0.01% |
38,050
+17,783
| +88% | +$442K |
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Energy.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 735 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.